Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. - Test2 - elhamkhani - TriplyDB

Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer.

Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer.

http://www.wikidata.org/entity/Q34329540

about

The genetic signatures of noncoding RNAs New small nuclear RNA gene-like transcriptional units as sources of regulatory transcripts Molecular evolution of the non-coding eosinophil granule ontogeny transcript New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines Genome-wide in silico identification and analysis of cis natural antisense transcripts (cis-NATs) in ten species Transcriptome analysis of antigenic variation in Plasmodium falciparum--var silencing is not dependent on antisense RNA Evaluation of reference-based two-color methods for measurement of gene expression ratios using spotted cDNA microarrays.Bioinformatics of Cancer ncRNA in High Throughput Sequencing: Present State and Challenges Androgen responsive intronic non-coding RNAs Sense-antisense pairs in mammals: functional and evolutionary considerations.Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk.Multivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostates Next-generation tag sequencing for cancer gene expression profiling.Alu and b1 repeats have been selectively retained in the upstream and intronic regions of genes of specific functional classes.Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes.Identification of protein-coding and non-coding RNA expression profiles in CD34+ and in stromal cells in refractory anemia with ringed sideroblasts.The reality of pervasive transcription.Perspectives of Long Non-Coding RNAs in Cancer Diagnostics Genomic landscape of developing male germ cells.Hidden treasures in unspliced EST data.Intronic RNAs constitute the major fraction of the non-coding RNA in mammalian cells.Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer.A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas.Pervasive transcription of the eukaryotic genome: functional indices and conceptual implications.NATsDB: Natural Antisense Transcripts DataBase Extensive relationship between antisense transcription and alternative splicing in the human genome.Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer.Natural antisense transcript: a concomitant engagement with protein-coding transcript Evolution of the unspliced transcriptome.Genomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers.Cigarette smoke exposure-associated alterations to non-coding RNA.Apert p.Ser252Trp mutation in FGFR2 alters osteogenic potential and gene expression of cranial periosteal cells.Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.Novel insight into the non-coding repertoire through deep sequencing analysis.Global analysis of biogenesis, stability and sub-cellular localization of lncRNAs mapping to intragenic regions of the human genome.Evolutionary conservation and functional roles of ncRNA.Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers.MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.Long non-coding RNA HOTAIR is a marker for hepatocellular carcinoma progression and tumor recurrence

P2860

Q21092463-2E9FC2EA-85DE-44BF-81B0-1F1837CF1398 Q21092499-26127777-CBDA-46A5-923D-E446729E5367 Q21131260-F27A306F-CA4A-40EB-8837-695D58BC1C2B Q21143810-C6AF16D4-8A75-449A-951E-35F22EEA7CCA Q24655583-92862DA2-BCC8-42E3-BFC2-E26D6B8E9C3C Q24685558-982E878D-2C55-4D18-B7EB-707E9761ACC1 Q24813703-4B63245F-21E2-4037-BFD6-3D425C0FE561 Q25255703-C6EED040-1C42-4B4D-BF76-DDA0D3071CB7 Q28710308-C23D369C-7CE0-40AA-8536-92C751865992 Q33270960-D3A0DB17-992D-4C5D-A12A-DFE2FDD5F454 Q33279356-619DD949-47F4-4224-B49E-FF34CC82F8CF Q33379607-AED1CD9F-EB50-42C6-B4D1-8969D712B686 Q33389634-5343A467-A224-470F-B70A-AFE2090DB055 Q33471106-4090E8D6-1172-4407-A3F4-E215B8503713 Q33519498-9491482D-D385-418B-9FB4-8E38D96E9EE2 Q33519740-135A47E1-78E2-4091-8A66-05DA53F15E1A Q33633465-2E3144C0-2DFB-404E-A766-C379FAE80125 Q33963677-74460CB4-7D31-4228-AC95-113547E2E3FD Q34031075-2D68DF77-70D6-4D4A-A574-ED0C00F407FD Q34129938-6FB273FD-D6B8-4BCF-B02D-5BD9E8A3A952 Q34224677-ADC4CD35-195E-4EDC-9077-99576F0E8250 Q34420404-A8E05FDE-AC69-4EFF-9C0D-41FD188F7097 Q34483455-C18E8ECA-9444-4E52-823C-78CFB61E0CF1 Q34552640-606FDC29-B2D4-4F5A-B22D-F1F3A7DC9EB8 Q35004344-27BC43B4-A827-4B30-9E65-610C204E50DD Q35128169-BAB4A0E1-421A-4E13-A6E1-B49C50779E24 Q35145469-D42AD5CE-13D2-4BCB-963F-5BB5297F05FA Q35576601-AA84C8BE-08E6-4971-A410-CC3BF863175C Q35640078-197B1167-4AC4-45D6-8AFB-66524A00F439 Q35750653-72D7647C-3FBE-45FA-AB53-2D75A6D7E8F0 Q35771477-BC2CF6FE-602C-4142-9143-5E1951DEB08C Q35875583-37ABAC76-906E-4B66-8634-739257FE7149 Q35951598-34119784-4B4F-4973-84B5-8977A01E31C0 Q35964148-59A0CB68-BA19-4F15-8D07-12508E575F62 Q36008219-EB39853C-3AEA-40FB-AC1F-55B08CD353BA Q36190172-52110618-4305-4B5B-B722-EFAE30A4D11F Q36304212-9DE48630-DB17-4638-903B-400CBC744E9E Q36546434-5082C6B9-9A9D-4B0F-9B61-0C86CE5716C3 Q36594516-0C4D7AB5-286E-426B-BCCF-3866E2CF2A9A Q36640592-A0B66245-EF8A-4E5B-9552-12BD6E28CC08

P2860

Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer.

http://www.wikidata.org/entity/Q34329540

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Antisense intronic non-coding ...... rentiation in prostate cancer.

@ast

Antisense intronic non-coding ...... rentiation in prostate cancer.

@en

Antisense intronic non-coding ...... rentiation in prostate cancer.

@nl

type

label

Antisense intronic non-coding ...... rentiation in prostate cancer.

@ast

Antisense intronic non-coding ...... rentiation in prostate cancer.

@en

Antisense intronic non-coding ...... rentiation in prostate cancer.

@nl

prefLabel

Antisense intronic non-coding ...... rentiation in prostate cancer.

@ast

Antisense intronic non-coding ...... rentiation in prostate cancer.

@en

Antisense intronic non-coding ...... rentiation in prostate cancer.

@nl

P1433

Q34329540-B2E27FDB-F57F-4205-929F-D5597C652E1F

P1476

Q34329540-2F8C329C-BAAE-4CEC-BF59-5EA4910C9840

P2093

Q34329540-042B1551-8450-405B-A1D7-8B01F405E046

Q34329540-0784BAD3-A6BC-4F2B-A3D4-854CBCE3F9A0

Q34329540-264EA71B-B69C-43BA-9637-95EDABC6C2F2

Q34329540-3219EBA5-D2EB-47FB-A5AF-FD57E91A2F8F

Q34329540-3971071B-EE71-48B8-B5F6-ACBC146255FD

Q34329540-3A1DC5F9-224C-49A7-BD4A-25D956F2F4EA

Q34329540-44BD7777-90AD-4C9E-9257-A3B74B60D888

Q34329540-4E0A9501-B08E-49C4-A46E-349515003A44

Q34329540-4ED4CDD9-F13C-42F1-9353-3DCC12D88F0A

Q34329540-605AEF75-DD90-4829-B190-E7B85B0C86EF

P2888

Q34329540-0A353C77-E836-48E5-B77C-2BEC729B5AD1

P304

Q34329540-685BEC44-5A8A-4E77-B418-9ED62A8CEAFA

P31

Q34329540-688759BA-F34D-4BD8-9875-63726851614F

P356

Q34329540-F09B9A84-26C1-48CB-AA64-C84DCEFD4944

P407

Q34329540-FEC58C1F-45B3-4107-8371-3231699CBB05

P433

Q34329540-871F009E-D9F6-456B-B7FE-9808D65B2686

P478

Q34329540-E8CB9195-AB44-4D75-9CE9-6AF5BBB23257

P50

Q34329540-062FBE84-F3A7-474A-A41D-AF57A55BAEEA

Q34329540-73D4A68C-A380-4EC0-A49B-69088D71A446

Q34329540-902B9AD0-F3CE-46C7-AED9-1BBAECC4F397

Q34329540-93AB5972-A283-428D-AC4D-66DF2AF6E2F7

Q34329540-BE814B57-79E8-473D-B6D2-6620F6D1F1AA

Q34329540-D8DCEC6C-DEB9-43EB-B864-BE2C5C765F5F

P577

Q34329540-1AB20A29-3B52-4F6F-A1E2-3874C5DD7222

P5875

Q34329540-841D2A0C-5B02-4033-9EBB-F1501332F660

P6179

Q34329540-830E9172-703C-4CF2-907A-3ACF1463F1B4

P698

Q34329540-7D91635D-B416-4525-B908-F4645E45E7C1

P921

Q34329540-D20DABFB-058B-46C8-B59E-4F56642931D9

P356

P1433

P1476

Antisense intronic non-coding ...... rentiation in prostate cancer.

@en

P2093

Abimael A Machado

http://www.w3.org/2001/XMLSchema#string

Apuã C Paquola

http://www.w3.org/2001/XMLSchema#string

Aurea V F Flatschart

http://www.w3.org/2001/XMLSchema#string

Camila M Egidio

http://www.w3.org/2001/XMLSchema#string

Camille C da Silva

http://www.w3.org/2001/XMLSchema#string

Carlos A Moreira-Filho

http://www.w3.org/2001/XMLSchema#string

Denise Yamamoto

http://www.w3.org/2001/XMLSchema#string

Etel Gimba

http://www.w3.org/2001/XMLSchema#string

Fernanda Festa

http://www.w3.org/2001/XMLSchema#string

Flavio C Canavez

http://www.w3.org/2001/XMLSchema#string

P2888

P304

6684-6692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1207880

http://www.w3.org/2001/XMLSchema#string

P407

P433

39

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Sergio Verjovski-Almeida

Aline Maria da Silva

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8487350

http://www.w3.org/2001/XMLSchema#string

P6179

1005029015

http://www.w3.org/2001/XMLSchema#string

P698

15221013

http://www.w3.org/2001/XMLSchema#string

P921